MRSN: Mersana Therapeutics Inc

7.32 USD 0.34 (4.44%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do MRSN para hoje mudou para -4.44%. Paralelamente, o preço mais baixo no mercado atingiu 7.32 e o mais alto foi 7.85.

Veja a dinâmica do par de moedas Mersana Therapeutics Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

MRSN Notícias

13:55 Wall Street Analysts Think Mersana Therapeutics (MRSN) Could Surge 248.83%: Read This Before Placing a Bet
15:55 Truist Securities slashes Mersana stock price target to $36 from $250
11:45 Guggenheim lowers Mersana stock price target to $30 from $125
17:49 Mersana stock price target raised to $17 from $6 at BTIG
15:44 Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript
12:15 Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Lags Revenue Estimates
11:28 Mersana Therapeutics earnings missed by $4.71, revenue fell short of estimates
21:10 Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates
23:20 VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Misses Revenue Estimates
11:45 Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Beats Revenue Estimates
12:15 Amicus Therapeutics (FOLD) Misses Q2 Earnings Estimates
12:46 Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested - TipRanks.com
14:47 Mersana Therapeutics stock tumbles on 1-for-25 reverse split plan
13:42 Mersana Therapeutics to implement 1-for-25 reverse stock split Friday
12:49 Mersana Therapeutics to implement 1-for-25 reverse stock split
12:28 Mersana reports promising Phase 1 ADC trial results
19:01 Mersana Therapeutics at TD Cowen Summit: Strategic Updates on Oncology Innovations
12:12 Mersana Therapeutics to Present at Upcoming Investor Conferences
20:04 Truist raises Mersana stock target to $10, maintains Buy rating
13:32 CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
11:32 Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
11:22 Mersana Therapeutics earnings matched, revenue fell short of estimates
18:00 Walmart, Deere, Applied Materials set to report earnings Thursday

Faixa diária

7.32 7.85

Faixa anual

0.26 8.19

Fechamento anterior: 7.66
Open: 7.78

Bid: 7.32
Ask: 7.62

Low: 7.32
High: 7.85

Volume: 86

Mudança diária: -4.44%
Mudança mensal: 9.91%

Mudança de 6 meses: 1281.13%
Mudança anual: 372.26%

30 agosto, sábado